Revenue

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Genomics Revenue	808.96M	451.75M	363.02M
Genomics Revenue Growth	79.07%	24.44%	83.36%
Data and Services Revenue	296.30M	241.65M	168.80M
Data and Services Revenue Growth	22.61%	43.16%	37.59%
Revenue (Total)	1.11B	693.40M	531.82M
Revenue (Total) Growth	59.40%	30.38%	65.85%

Key Performance Indicators

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Remaining Total Contract Value (TCV)	940.00M	920.00M
Remaining Total Contract Value (TCV) Growth	2.17%	-
Additional Potential Future Opt-Ins	300.00M	300.00M
Net Revenue Retention	140.00%	125.00%

Updated Sep 30, 2025. Data Source: Fiscal.ai.